Virginia’s House of Delegates by a vote of 65-32 approved the revised bill, which calls for women to undergo an abdominal ultrasound but not necessarily a more invasive internal one as required under the original measure. Whether the Senate will now follow suit remains in doubt.

Satirized by television comedians and savaged by opponents, the original version of the bill supported by McDonnell drew a large crowd of protesters to the state capital in Richmond earlier this week.

A petition sent to McDonnell urging him to veto the bill contained more than 33,000 signatures, according to NARAL Pro-Choice Virginia Executive Director Tarina Keene.

At the last minute, McDonnell, an abortion opponent and possible contender for vice president, withdrew his support and asked for changes to the bill.

“Mandating an invasive procedure in order to give informed consent is not a proper role for the state,” McDonnell said.

“I am requesting that the General Assembly amend this bill to explicitly state that no woman in Virginia will have to undergo a transvaginal ultrasound involuntarily.”

The approved legislation would require a woman to undergo a non-invasive ultrasound, and she would have the option to choose or decline a more invasive probe if deemed necessary by a doctor. Under the original bill, a woman would have been compelled to have the more invasive probe.

The revised measure also would require that women be given the opportunity to view the fetal ultrasound image prior to an abortion.

After the governor’s about-face, Democrats on the House floor sought to build on the momentum by calling for the bill to be killed entirely.

“You’re mandating not only a completely unnecessary procedure, but a useless one,” Democratic Delegate Jennifer McClellan said.

Other Democrats pressed for more time to study the new measure.

“We got this statement from the governor a half hour ago that he doesn’t like the old bill, and he’s instructing the General Assembly to come up with something new,” Democratic Delegate David Toscano said.

“We need to be spending a bit of time on this bill,” he said. “We shouldn’t be playing doctor on the House floor.”

While Virginia House Republicans prevailed and the amended bill passed, its future in the Senate is in question.

Republican Senator Jill Holtzman Vogel, the bill’s sponsor, announced on Wednesday that she planned to strike the bill entirely when it comes up for review in her chamber, according to the lawmaker’s assistant.

Six other states have passed laws requiring abortion providers to perform an ultrasound on each woman seeking an abortion and give the woman an opportunity to view the image, according to the Guttmacher Institute, which studies reproductive health issues.

While most of those states allow women to decline to view the image, Texas, Oklahoma and North Carolina require women to hear the provider’s verbal description of the ultrasound.

The laws in Oklahoma and North Carolina are temporarily unenforceable, pending court challenges. But the U.S. Court of Appeals for the 5th Circuit cleared the way for enforcement of the Texas law in January.

The analysis of nearly 2,300 Mexican Americans aged 12 to 19 years of age in the National Survey of U.S. health examination. States. 1999 to 2004 found that children born in families of second and third generations were more likely to be obese than those who were not born in the U.S. (first generation).

Compared with the young Mexican-American first-generation, second generation were 2.5 times more likely to be obese, and the third generation were twice as likely to be obese, the researchers found the University of South Carolina .

The study appears in the February issue of the Journal of Nutrition.

Young Mexican Americans second and third generation have diets rich in saturated fat and sodium and consume large amounts of sugary drinks. Their consumption of fruits, vegetables, grains, meat and beans was less than first-generation youth.

The researchers noted that the typical Mexican diet includes corn, beans, meat such as pork and fish, fruits like pineapple and papaya, and vegetables such as zucchini and avocado.

“The Mexican-American children are disproportionately affected by obesity. This has serious public health consequences, given that Mexican Americans are the segment of the fastest growing population. The study of this population is very important, “he said in a news release from the university study lead author Jihong Liu.

He noted that many immigrant families can not afford fruits, vegetables and other healthy foods, which are more expensive than less healthy foods.

“Our findings also suggest that you should implement policies and programs to help immigrants to protect their traditional dietary practices, such as a high intake of fruits, vegetables and bread as they try to assimilate to American culture and society”, stated Liu. “Future studies should continue to examine the barriers faced by Mexican-American adolescents to maintain their native diet and identify strategies to address those barriers.”

Right now, the practical uses of research appear to be limited but doctors could conceivably be tested for the mutation in people and advised to avoid certain diets, said study co-author Dr. Gozoh Tsujimoto, professor of science genomic drug discovery at the University of Kyoto, Japan. Tsujimoto stated that eventually could also be possible to give people drugs to combat the effects of the mutation.

If this happens, there could be “a new way to personalized health care,” said Tsujimoto.

Scientists have studied the genetic links to obesity that might make some people tend to accumulate weight. Two thirds of Americans are overweight or obese calculate the Centers for Disease Control and Prevention (CDC). States Excess weight contributes to a variety of diseases including heart disease and cancer.

In the new study, researchers looked the part of the internal communication system of the body that has to do with the regulation of appetite and fat cell production.

The researchers found that mice lacking this component were 10 percent more fat than other mice when all women were given a diet rich in fat. The mice developed without the component also increased glucose intolerance.

Research carried out on animals is not always applicable to humans, and much more study is needed. However, the researchers found that Europeans with the genetic mutation, called GPR120, were much more likely to be obese.

“Our study showed for the first time the gene responsible for diet-induced obesity,” said Tsujimoto.

According to Tsujimoto, more than three percent of Europeans carry the trait. The next step for researchers is to study its prevalence in Japanese, Korean and Chinese.

What can be done with the knowledge of the trait?

Tsujimoto said doctors would advise people who have the trait to avoid high-fat diets. There is a test available to detect the trait, and costs about $ 200 in Japan, Tsujimoto said.

Although potentially could develop drugs that reverse the effects of genetic trait, not yet exist, Tsujimoto said.

Ruth Loos, Director of Genetics of Obesity and Related Metabolic Traits in the Mount Sinai School of Medicine in New York City, said that “these findings provide another piece of what has proved a great puzzle that describes the causes of obesity. ”

Consistent findings in mice and humans have placed the feature “on the map of obesity more strongly, and provide a new starting point for more research on the role of this gene,” said Loos.

“This is just the beginning of what will likely be many years of research to unravel the physiological mechanisms underlying the relationship between this gene and the risk of obesity,” he said. “We can only think about the development of a drug when we better understand the physiology and biology.”

Researchers compared to almost 20,000 women aged 35 years with no history of cancer with 2.713 women who had survived cancer. Both groups underwent mammography for breast cancer.

Cancer survivors between 30 and 49 years of age had higher smoking rates than women with no history of cancer. The cancer survivors were also less likely to exercise vigorously, and more likely to rate their health as “poor”.

However, cancer survivors were less likely to drink alcohol at least once a month.

The body mass index (a measure of body fat for height and weight of the person) did not differ between groups. But cancer survivors reported less weight gain than the group without cancer in the previous five years, according to study author Sarah Rausch, a clinical psychologist and director of integrative medicine at Moffitt Cancer Center Tampa, Florida, and colleagues.

The study appears in a recent issue of the American Journal of Clinical Oncology.

It is possible that women who have survived cancer may benefit from programs to encourage them to adopt healthier habits, the researchers said.

“Differences in health behaviors among cancer survivors and those who have no history of the disease provide a ‘teachable moment’ in which a survivor can motivate behavior change to encourage a healthier lifestyle and prevent recurrence of cancer, “Rausch said in a news release from Moffitt.

“As the population of cancer survivors increases, the importance of health status and quality of life of survivors is even more critical,” he said Rausch. “Approximately 10.5 million people in USA. States. Have been diagnosed with cancer. Because of advances in diagnosis and treatment of disease, there is a growing population of cancer survivors.”

The new study included 963 members of the Army National Guard of Ohio who said they had never abused alcohol before entering active duty. Between June 2008 and February 2009, nearly twelve percent (113 soldiers) reported alcohol abuse disorder that first occurred during or after deployment.

Among those soldiers, 35 reported depression (31 percent), 23 reported PTSD (20 percent), and 15 reported both conditions (13 percent) during the monitoring period.

Surprisingly, alcohol abuse was uncommon among the small number of soldiers with PTSD or depression history prior to deployment, according to researchers.

The study authors, led by Brandon Marshall of the Mailman School of Public Health of Columbia University, found that the soldiers at risk for alcohol abuse were mostly new-onset men (97 percent) and less than 35 years (74 percent). Most had only been deployed once and more recently to a conflict zone.

The study was published online Feb. 16 in advance of publication in an upcoming print issue of the journal Drug and Alcohol Dependence.

“A novel finding of our study is to develop depression or PTSD during or after the deployment was a potent risk factor for alcohol problems suffer in the same period,” Marshall said in a news release from the university.

Soldiers who develop depression or PTSD may self-medicate with alcohol to cope with negative feelings and stress of deployment, they suggested.

However, although the study found an association between deployment and the abuse of alcohol, does not demonstrate a cause and effect.

“The high prevalence of alcohol abuse during and after deployment observed here suggests that policies that promote better access to care and confidentiality merit further consideration,” concluded Marshall.

However, they found that children of mothers who consumed less vitamin D during pregnancy had language problems at age 10 (18%) compared to the descendants of the other group (8%).

“If vitamin D deficiency during the prenatal stage is triggered by language problems in childhood, then the addition of vitamin D in pregnant women can be helpful”, he explained the expert.

Previous studies have linked low vitamin D intake during pregnancy with childhood problems such as brittle bones, asthma or poor growth, although not linked with language problems. Thus, the principal investigator has lamented that “the effects of low vitamin D intake in the child’s development are not understood at all” by society.

Finally, other researchers have suggested obesity include in future studies in this field. “We know that obese mothers are more likely to have children with developmental delays and cognitive problems,” he explained Lisa Bodnar, professor at the University of Pittsburgh, located in the United States.

That is the heart of an important current debate in the world of psychiatry, while the American Psychiatric Association (American Psychiatric Association, APA) is preparing to publish the fifth edition of his important reference guide for mental health, the diagnostic manual and Statistical of Mental Disorders (DSM).

The problem is that for the first time the manual, a cornerstone for mental health professionals all over U.S.. States., Could not exclude the concept of “duel” of the constellation of behaviors and experiences thought to warrant consideration when clinicians seeking to diagnose major depressive disorder.

What does this mean? These feelings or outbursts that accompany the death of a relative or close friend (such as crying, insomnia, fatigue, confusion and deep sadness) may now be regarded as a treatable disease rather than a normal reaction to the times most devastating of life.

Needless to say, not everyone agrees with this change of opinion.

“For me, grief is a normal condition, which should not be labeled with a diagnosis code or treaty,” said Dr. T. Byram Karasu, chairman of psychiatry and behavioral sciences at Albert Einstein College of Medicine and chief psychiatrist at Montefiore Medical Center in New York City. “At some point in their lives, everyone experiences a loss. So this would be to classify everyone at some point. Nobody would be immune.”

“And this is nonsense, because grief is a normal behavior and very healthy,” said Karasu, who is also president of the National Working Group on the treatment of depression of the APA. “You have to feel joy and pain and depression, otherwise life is not worth it. And should not interrupt the duel with drugs or psychotherapy. You have to feel the loss, and just feel it and it will recover one becomes a better person. Mourning becomes interrupted a pending issue. ”

Karasu’s position concurs with the views expressed by the editorial board of the British medical journal The Lancet, who presented his opposition to the new clinical approach in its issue of February 18.

“Grief is not a disease,” raise the editors of the journal, and note that a change in the next diagnostic manual of the APA would give clinicians the power to interpret any anxiety after a loss that lasts more than two weeks as a worrying sign of disease rather than a standard signal of coping.

The team from the Lancet suggests that, instead, an intense but normal grief may last from six months to a year depending on the individual nature of the special relationship has broken death.

“Medicalizing grief that routinely legitimize the treatment with antidepressants, for example, not just something dangerously simplistic, but wrong,” the authors noted.

However, they recognized that sometimes the match itself can become much more complex, durable and “pathological.” In such cases, there could be a real clinical depression with features of a supposed “prolonged grief disorder”, a new potential designation is being considered by the World Health Organization. And the board concurred that these patients could benefit from some form of mental health intervention.

Concern about exactly when normal grief becomes a condition that might warrant treatment is what drives the idea of inclusion in the DSM, said Dr. Sidney Zisook, a professor of psychiatry at the University of California, San Diego .

“It has been well recognized that the death of a loved one, like any other intense stressor [as] job loss, the diagnosis of a fatal disease or divorce can trigger clinical depression,” he said. “Depressive symptoms are no less serious result or when the cause debilitating grief when they do happen after any other life event, or indeed when depression seems to come from nowhere.”

“Recognize that grief can be a major stressor that may trigger clinical depression in a vulnerable person or pathologized medicalizes not mourning,” he suggested. “Instead, it prevents clinical depression is obviated or ignored, and facilitates the possibility of proper treatment.”

Zisook warned that “this recognition does not mean we think that acute grief is to end in days, weeks or even months. In some people could take years, there are also clinical depression or not. But recognizing that clinical depression can also occur in some individuals bereaved could do much to help these individuals regain their lives. ”

For Dr. Randolph M. Nesse, professor of psychiatry at the Medical Faculty of the University of Michigan, the discussion is summarized in a tug and pull between the basic common sense on the one hand and the pursuit of the science of diagnostic consistency on the other.

“We all know that grief is something that happens to everybody,” he said. “And just because an emotion does not mean it hurts bad or unhealthy. Most times it is a common sense answer to a real problem.”

“So for me it would make sense to eliminate the exclusion criteria of mourning [DSM],” said Nesse, who is also professor of psychology at the College of Literature, Science and Arts of the UM. “But since it is so difficult to find out when an emotion is normal or not without really knowing what happens in the life of the person, having a classification system for diagnosing depression that is practical, simple and easy carries undeniable advantages. Facilitates things. So the match is included in a section to fill, whether you have a real problem to diagnose or not. ”

“But that’s worrisome,” he added. “Because when someone is diagnosed with depression, encouraged to be given treatment. And such treatment requires the person being treated to believe they really have a problem that requires treatment. And that can be harmful in many cases that grief is actually a normal and healthy response to a life event. “

“The current environment for heart failure has improved substantially, and the future promises that really has deleted the term ‘failure’ of the description of this disease,” said Dr. Gregg Fonarow, director of the Ahmanson-UCLA Cardiomyopathy in Los Angeles and co-director of Preventive Cardiology Program of the David Geffen School of Medicine at UCLA.

Dr. Clyde Yancy, a former president of the American Heart Association and chief of cardiology at Northwestern Memorial Hospital in Chicago, supported the idea, and pointed to what he sees as “the dawn of a new era” in which advances in the treatment allow doctors to “remove the weight, the drama and the ‘failure’ of heart failure.”

To promote public awareness, the American Heart Association has designated this week as the national week of awareness about heart failure.

Heart failure is a poorly understood medical condition, and symptoms include extreme fatigue, weakness and / or shortness of breath, as years of poor nutrition, inactivity, hypertension, high cholesterol, overweight and related health complications such as diabetes, cumulative charge a price to a heart that is growing weaker and more.

In turn, the heart muscle endeavors, and ultimately insufficient to carry out its duty to pump blood (and oxygen it carries) throughout the body. This makes everyday activities like walking or climbing stairs are an important effort for patients. It is estimated that heart failure affects six million men and women in America.

“Any person in the population over 40 has 20 percent chance of developing heart failure, regardless of medical history,” said Yancy. “In short, this means that everyone is at risk. And of course, those with a history of heart disease are at risk even higher.”

However, Yancy noted, “a few years ago we did not have anything we could say it was particularly encouraging. It was not a disease for which there was much hope or optimism. Now, everything has changed completely.”

Why?

Fonarow credits the change to a decade of innovation in drug and medical devices. On the one hand, have arisen entirely new classes of drugs such as ACE inhibitors, beta blockers and aldosterone antagonists, which help reduce the risk of developing heart failure, while expanding treatment options when occurs.

And Yancy added that “we also know that cardiac rehabilitation (ie, a regime of exercise) can help. Years ago, we told patients who were taking it easy. But now we know that in reality a vigorous active lifestyle is better. ”

At the same time, Fonarow noted the emergence of small implantable electrical devices that are affordable and effective, which have helped doctors to better control the type of electrical disturbance of the heart that can affect normal function.

“Even for patients with advanced disease, the utility of mechanical support (with artificial cardiac pump devices) has become something amazing,” Fonarow noted. “We can keep patients long enough to allow not only a heart transplant, but also serves as a definitive therapy for something even more attractive, supporting the recovery of heart muscle function.”

The result: in the last decade, hospitalizations for heart failure have actually declined, while the risk of death was reduced from 65 to 80 percent, Fonarow said. “What was once a bleak and depressing diagnosis, with a mortality rate five years more than 50 percent, is now a clinical setting in the emerging optimism and new hope.”

The future of treatment for heart failure is even brighter, Yancy said, given the advances that are taking place in protein therapies, genetic and stem cell transplant, designed to help patients recover even more after a heart attack.

“Let this become a reality at all entail a little more time,” he said Yancy. “But surely coming our way.”

That said, supports the status quo is not entirely encouraging, as U.S. hospitals today. States. attend each year to approximately 500,000 new cases of heart failure.

The key to reducing this figure is to help the public understand the relationship between unhealthy lifestyles and heart damage.

“Many people do not have a clear idea of ​​what is heart failure,” said Yancy. “Usually, people think about their risk of a dramatic event like a heart attack. But heart failure should be on everyone’s mind, because it takes place quietly over time, as the heart takes loads such as obesity, diabetes and smoking, “he said.

“So it’s important to mobilize the public to let everyone know that heart failure is treatable, but preventable,” Yancy said. “For though we can not cure it, we do know to manage it. Can not be addressed as inevitable. Because it is not.”

The findings of the RAND Corporation, a research organization nonprofit, are based on calculations created using a computer model. The researchers found that removing the clause “individual obligation” would increase the cost of an individual to buy insurance at 2.4 percent, and reduce the number of Americans who would get new health coverage in 2016 from 27 to 15 million.

“Our analysis suggests that eliminating the requirement would sharply reduce individual coverage, but premiums would not lead to a” death spiral “that would make health insurance affordable for not those who do not qualify for government subsidies,” he said in a statement release from the RAND lead author Christine EIBNER economist of the organization.

The analysis also found that individual binding repeal would greatly increase the amount of government spending per person newly enrolled in a health insurance plan. The cost would more than double, to $ 7.468 per person.

“The individual requirement is critical not only to achieve health care coverage nearly universal among Americans, but to pay a high value in terms of federal spending to expand coverage,” said EIBNER. “Without the individual requirement, the government should spend more in general to ensure fewer people.”

The U.S. Supreme Court. States. approaches will hear in March on the constitutionality of requiring all Americans to obtain health insurance.

Perhaps one day scientists could use brain scans to track the effectiveness of drugs designed to treat Alzheimer’s. The disorder, which affects the brain, currently has no cure, and drugs can not stop its progress.

The scanners can detect a chemical marker developed by the researchers that links to the plate (a kind of brain dirt) and “tangles”, both related to Alzheimer’s disease. The researchers evaluated the effectiveness of the method in 43 healthy subjects of the study, with an average age of 64. Almost half of the volunteers had a form of memory loss known as “mild cognitive impairment.”

The study findings appear in the February issue of the journal Archives of Neurology .

“We found that this could be a useful marker of brain imaging that can detect changes early, before symptoms appear and may be useful to track changes in the brain over time,” he said in a press release from the University of California study author Dr. Gary Small, professor of psychiatry at the Semel Institute for Neuroscience and Human Behavior University in Los Angeles.

The researchers found they could relate the results of the scanner with mental decline after two years and even could use the findings of the initial scans to predict some types of brain decline in participants two years later.

The next step is to use the scanners to study the effectiveness of drugs designed to treat aging brain, and the therapies used to try to delay or prevent Alzheimer’s, Small said in the press release.

In response to the question of whether the scans could be useful for patients at this time, Catherine Roe, research assistant professor in neurology and Alzheimer’s specialist at Washington University in St. Louis, who was not involved in the study, said that doctors have other ways of detecting mental decline, and still there is no preventive treatment for Alzheimer’s disease.

But “although I do not think the technology is ready for application in doctors now believe it would be clinically useful to help determine the underlying cause of the decline [mental], if Alzheimer’s or something else,” said Roe.